J&J Asks to Keep Risperdal Studies Under Seal

1
288

Law 360 reports that Johnson & Johnson asked a Pennsylvania judge to keep a series of clinical studies related to the drug Risperdal under seal, saying that the plaintiffs were improperly seeking to publicly release them.

Article →

1 COMMENT

LEAVE A REPLY